Recombinant Mouse VEGF164 Protein(P. pastoris)

Vascular endothelial growth factor (VEGF) is a crucial signaling protein involved in vasculogenesis and angiogenesis, playing a significant role in both normal physiological processes and pathological conditions such as cancer, diabetic retinopathy, and age-related macular degeneration. Among various isoforms of VEGF, VEGF164, particularly in humans, has garnered considerable attention due to its potent ability to stimulate endothelial cell proliferation and migration, thereby promoting the formation of new blood vessels. The significance of VEGF164 in tumor progression and inflammation has prompted researchers to investigate its molecular mechanisms and therapeutic potential. Generating recombinant VEGF164 protein enables studies on its structure-function relationship, receptor interactions, and downstream signaling pathways at a molecular level. Furthermore, recombinant VEGF164 serves as a valuable tool in drug development and bioengineering, with applications ranging from wound healing to tissue engineering. Understanding the properties and functionalities of VEGF164 from a biological perspective is essential for creating targeted therapies that can mitigate diseases associated with abnormal angiogenesis. As research progresses, VEGF164's role in regenerative medicine and targeted cancer therapies continues to evolve, making it an important focus for ongoing scientific investigations.